| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.02 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.64 | 0.02 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.39 | 0.02 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.24 | 0.02 |